Abstract:Cluster randomized trials (CRTs) are studies where treatment is randomized at the cluster level but outcomes are typically collected at the individual level. When CRTs are employed in pragmatic settings, baseline population characteristics may moderate treatment effects, leading to what is known as heterogeneous treatment effects (HTEs). Pre-specified, hypothesis-driven HTE analyses in CRTs can enable an understanding of how interventions may impact subpopulation outcomes. While closed-form sample size formulas have recently been proposed, assuming known intracluster correlation coefficients (ICCs) for both the covariate and outcome, guidance on optimal cluster randomized designs to ensure maximum power with pre-specified HTE analyses has not yet been developed. We derive new design formulas to determine the cluster size and number of clusters to achieve the locally optimal design (LOD) that minimizes variance for estimating the HTE parameter given a budget constraint. Given the LODs are based on covariate and outcome-ICC values that are usually unknown, we further develop the maximin design for assessing HTE, identifying the combination of design resources that maximize the relative efficiency of the HTE analysis in the worst case scenario. In addition, given the analysis of the average treatment effect is often of primary interest, we also establish optimal designs to accommodate multiple objectives by combining considerations for studying both the average and heterogeneous treatment effects. We illustrate our methods using the context of the Kerala Diabetes Prevention Program CRT, and provide an R Shiny app to facilitate calculation of optimal designs under a wide range of design parameters.

Design-Based RCT Estimators and Central Limit Theorems for Baseline Subgroup and Related Analyses

Design-Based Estimation and Central Limit Theorems for Local Average Treatment Effects for RCTs

A Lasso-OLS Hybrid Approach to Covariate Selection and Average Treatment Effect Estimation for Clustered RCTs Using Design-Based Methods

Subgroup identification in clinical trials: an overview of available methods and their implementations with R

Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups

Precise unbiased estimation in randomized experiments using auxiliary observational data

Data-driven Design of Randomized Control Trials with Guaranteed Treatment Effects

Uncovering individualised treatment effects for educational trials

Maximin optimal cluster randomized designs for assessing treatment effect heterogeneity

RCT Rejection Sampling for Causal Estimation Evaluation

The Design Versus the Analysis of Observational Studies for Causal Effects: Parallels with the Design of Randomized Trials

Finely Stratified Rerandomization Designs

Detecting critical treatment effect bias in small subgroups

Comparing Approaches to Treatment Effect Estimation for Subgroups in Clinical Trials

Leveraging baseline covariates to analyze small cluster-randomized trials with a rare binary outcome

Using Power Analysis to Choose the Unit of Randomization, Outcome, and Approach for Subgroup Analysis for a Multilevel Randomized Controlled Clinical Trial to Reduce Disparities in Cardiovascular Health

Designing Experiments Toward Shrinkage Estimation

Randomization to Randomization Probability: Estimating Treatment Effects under Actual Conditions of Use.

E- and R-optimality of block designs for treatment-control comparisons

Estimating subgroup effects in generalizability and transportability analyses

Causal Inference in Rebuilding and Extending the Recondite Bridge Between Finite Population Sampling and Experimental Design